Ballot Initiative Takes Shape to Give California Stem Cell Agency a Second Life

November 18, 2019

(Science) – As California’s stem cell research agency runs through the last of its $3 billion in state funding, a delicate negotiation is underway between its leadership and the man developing the 2020 ballot initiative to keep it alive. Robert Klein, the real estate investment banker behind the 2004 ballot initiative that created the California Institute for Regenerative Medicine (CIRM) in Oakland, last month submitted a new proposal to the California attorney general’s office that would allocate another $5.5 billion in proceeds from state bond sales to the agency.